OncoSec Medical Inc (ONCSQ)

[chickpea598]

Dr. Pierce said he joined Oncosec because they had the ability to help the 60-70% of the population of non-responders to Keytruda. Dr. Pierce spent many years working on Keytruda at Merck so joining Oncosec was the next step in advancing Keytruda to a higher level using Oncosec technology. There is a huge unmet need that can be remedied and Dr. Pierce obviously saw the potential to achieve this goal at Oncosec.